Evidence mapPaperPMID 35899591Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2022

'Much more convenient, just as effective': Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.

Molly L Tanenbaum, Dessi P Zaharieva, Ananta Addala, Priya Prahalad, Julie A Hooper, Brianna Leverenz, Ana L Cortes, Nora Arrizon-Ruiz, Erica Pang, Franziska Bishop and 1 more

Abstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  5. Article
  6. Article
  7. Role and Perspective of Certified Diabetes Care and Education Specialists in the Development of the 4T Program.Diabetes spectrum : a publication of the American Diabetes Association · 2024
    Article
  8. Institutional Barriers to the Successful Implementation of Telemedicine for Type 1 Diabetes Care.Clinical diabetes : a publication of the American Diabetes Association · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Molly L TanenbaumDivision of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0003-4222-4224
Dessi P ZaharievaDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-9374-8469
Ananta AddalaDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-0508-4309
Priya PrahaladDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-3894-4344
Julie A HooperDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Brianna LeverenzDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Ana L CortesDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Nora Arrizon-RuizDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Erica PangDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Franziska BishopDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
David M MaahsDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-4602-7909

Funding

Stanford Islet Research CoreP30DK116074 · STANFORD UNIVERSITY · 2025 to 2025
$2.0M
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T StudyR18DK122422 · NIDDK · STANFORD UNIVERSITY · PI David Matthew Maahs · 2022 to 2022
$678k
Training Research Leaders in Type 1 DiabetesK12DK122550 · NIDDK · STANFORD UNIVERSITY · PI David Matthew Maahs · 2023 to 2023
$649k
ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes DevicesK23DK119470 · NIDDK · STANFORD UNIVERSITY · PI Molly Leah Tanenbaum · 2022 to 2023
$339k
Reducing Disparities in Pediatric Diabetes: Building the Evidence Base to Inform Effective Diabetes Technology Interventions in Underrepresented MinoritiesK23DK131342 · STANFORD UNIVERSITY · 2025 to 2025
$194k
NIDDK NIH HHS K12 DK122550NIDDK NIH HHS K23 DK119470NIDDK NIH HHS K23 DK131342NIDDK NIH HHS L30 DK137378NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R18 DK122422
6 · The paper itself

Abstract

aimInitiating continuous glucose monitoring (CGM) shortly after Type 1 diabetes diagnosis has glycaemic and quality of life benefits for youth with Type 1 diabetes and their families. The SARS-CoV-2 pandemic led to a rapid shift to virtual delivery of CGM initiation visits. We aimed to understand parents' experiences receiving virtual care to initiate CGM within 30 days of diagnosis.

methodsWe held focus groups and interviews using a semi-structured interview guide with parents of youth who initiated CGM over telehealth within 30 days of diagnosis during the SARS-CoV-2 pandemic. Questions aimed to explore experiences of starting CGM virtually. Groups and interviews were audio-recorded, transcribed and analysed using thematic analysis.

resultsParticipants were 16 English-speaking parents (age 43 ± 6 years; 63% female) of 15 youth (age 9 ± 4 years; 47% female; 47% non-Hispanic White, 20% Hispanic, 13% Asian, 7% Black, 13% other). They described multiple benefits of the virtual visit including convenient access to high-quality care; integrating Type 1 diabetes care into daily life; and being in the comfort of home. A minority experienced challenges with virtual care delivery; most preferred the virtual format. Participants expressed that clinics should offer a choice of virtual or in-person to families initiating CGM in the future.

conclusionMost parents appreciated receiving CGM initiation education via telehealth and felt it should be an option offered to all families. Further efforts can continue to enhance CGM initiation teaching virtually to address identified barriers.

Indexed as

COVID-19Diabetes Mellitus, Type 1AdolescentAdultBlood GlucoseBlood Glucose Self-MonitoringChildChild, PreschoolCOVID-19 TestingFemaleHumansMaleMiddle AgedQuality of LifeSARS-CoV-2Blood Glucosechildren and adolescentscontinuous glucose monitoringhealthcare deliverypsychological aspectstelehealthtype 1 diabetes

Identifiers

PMID35899591
PMCPMC9579993

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.